FI872801A0 - Foerfarande foer anvaendning av bar1 foer avsoendring av fraemmande proteiner. - Google Patents

Foerfarande foer anvaendning av bar1 foer avsoendring av fraemmande proteiner.

Info

Publication number
FI872801A0
FI872801A0 FI872801A FI872801A FI872801A0 FI 872801 A0 FI872801 A0 FI 872801A0 FI 872801 A FI872801 A FI 872801A FI 872801 A FI872801 A FI 872801A FI 872801 A0 FI872801 A0 FI 872801A0
Authority
FI
Finland
Prior art keywords
foer
fraemmande
avsoendring
proteiner
bar1
Prior art date
Application number
FI872801A
Other languages
English (en)
Finnish (fi)
Other versions
FI872801A7 (fi
Inventor
Vivian L Mackay
Original Assignee
Vivian L Mackay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vivian L Mackay filed Critical Vivian L Mackay
Publication of FI872801A7 publication Critical patent/FI872801A7/fi
Publication of FI872801A0 publication Critical patent/FI872801A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/58Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
    • C12N9/60Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi from yeast
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/10Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/50Fusion polypeptide containing protease site
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
FI872801A 1985-10-25 1987-06-24 Foerfarande foer anvaendning av bar1 foer avsoendring av fraemmande proteiner. FI872801A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79130585A 1985-10-25 1985-10-25
PCT/US1986/002198 WO1987002670A1 (en) 1985-10-25 1986-10-20 Method of using bar1 for secreting foreign proteins

Publications (2)

Publication Number Publication Date
FI872801A7 FI872801A7 (fi) 1987-06-24
FI872801A0 true FI872801A0 (fi) 1987-06-24

Family

ID=25153298

Family Applications (1)

Application Number Title Priority Date Filing Date
FI872801A FI872801A0 (fi) 1985-10-25 1987-06-24 Foerfarande foer anvaendning av bar1 foer avsoendring av fraemmande proteiner.

Country Status (13)

Country Link
EP (1) EP0243465A1 (cs)
JP (1) JP2523562B2 (cs)
CN (1) CN1027179C (cs)
AU (2) AU6543286A (cs)
CA (1) CA1316133C (cs)
CZ (1) CZ284251B6 (cs)
DK (1) DK320287D0 (cs)
FI (1) FI872801A0 (cs)
HU (1) HU206897B (cs)
IE (1) IE63822B1 (cs)
SK (1) SK776486A3 (cs)
UA (1) UA41863C2 (cs)
WO (1) WO1987002670A1 (cs)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK58285D0 (da) * 1984-05-30 1985-02-08 Novo Industri As Peptider samt fremstilling og anvendelse deraf
EP0310137B1 (en) * 1987-10-02 1994-01-26 Zymogenetics, Inc. BAR1 secretion signal
US5206699A (en) * 1988-05-06 1993-04-27 Gersan Establishment Sensing a narrow frequency band of radiation and gemstones
AU633020B2 (en) * 1988-07-23 1993-01-21 Novozymes Delta Limited New secretory leader sequences
AU7493491A (en) * 1990-03-13 1991-10-10 Hawaii Biotechnology Group, Inc. (neurospora) expression system
DK82893D0 (da) * 1993-07-08 1993-07-08 Novo Nordisk As Peptid
BRPI9607646B1 (pt) 1995-03-17 2016-07-05 Novo Nordisk As vetor de expressão recombinante, célula fúngica, método para produzir uma enzima apresentando atividade de endoglucanase e para prover clarificação da cor nas roupas de lavagem, composição de lavanderia , uso da enzima, e, composição de enzima
DK1975177T3 (da) 1996-03-01 2011-07-25 Novo Nordisk As Appetitundertrykkende peptid, formuleringer dermed og anvendelse deraf
DE60139110D1 (de) 2000-01-10 2009-08-13 Maxygen Holdings Ltd G-csf konjugate
DE60138364D1 (de) 2000-02-11 2009-05-28 Bayer Healthcare Llc Gerinnungsfaktor vii oder viia konjugate
CA2469846A1 (en) 2001-02-27 2002-09-26 Maxygen Aps New interferon beta-like molecules
AU2002249096B2 (en) 2001-03-22 2007-06-28 Novo Nordisk Health Care Ag Coagulation factor VII derivatives
US6534059B2 (en) 2001-06-05 2003-03-18 Advanced Biotherapy, Inc. Compositions and methods for treating hyperimmune response in the eye
MXPA04002833A (es) 2001-09-27 2004-07-15 Novo Nordisk Healthcare Ag Polipeptidos de factor vii de coagulacion humano.
CN101870729A (zh) 2003-09-09 2010-10-27 诺和诺德医疗保健公司 凝固因子ⅶ多肽
EP2360181B1 (en) 2005-04-18 2013-09-18 Novo Nordisk A/S IL-21 variants
US9056921B2 (en) 2005-08-16 2015-06-16 Novo Nordisk A/S Method for making mature insulin polypeptides
EP2316930A1 (en) 2005-09-14 2011-05-04 Novo Nordisk Health Care AG Human coagulation factor VII polypeptides
US20100159512A1 (en) 2006-03-06 2010-06-24 Kurt Osther Method for the preparation of recombinant human thrombin and fibrinogen
CA2663083A1 (en) 2006-09-08 2008-03-13 Ambrx, Inc. Modified human plasma polypeptide or fc scaffolds and their uses
WO2008037735A1 (en) 2006-09-27 2008-04-03 Novo Nordisk A/S Method for making maturated insulin polypeptides
EP2076533B1 (en) 2007-05-02 2014-10-08 Ambrx, Inc. Modified interferon beta polypeptides and their uses
MX338336B (es) 2007-11-20 2016-04-07 Ambrx Inc Polipeptidos de insulina modificados y sus usos.
PL3225248T3 (pl) 2008-07-23 2023-11-27 Ambrx, Inc. Zmodyfikowane polipeptydy bydlęcego G-CSF i ich zastosowania
US8349325B2 (en) 2008-12-23 2013-01-08 Abbott Laboratories Soluble FMS-like tyrosine kinase-1 (sFLT-1) antibody and related composition, kit, methods of using, and materials and method for making
EP2406282A1 (en) 2009-03-11 2012-01-18 Novo Nordisk A/S Interleukin-21 variants having antagonistic binding to the il-21 receptor
US20120282285A1 (en) 2009-07-17 2012-11-08 Rigshospitalet Masp isoforms as inhibitors of complement activation
CN102666570B (zh) 2009-12-01 2015-12-02 诺沃—诺迪斯克有限公司 新的肽基α-羟基甘氨酸α-酰胺化裂合酶
EP2516454A4 (en) 2009-12-21 2013-05-22 Ambrx Inc MODIFIED BOVINE SOMATOTROPIN POLYPEPTIDES AND ITS USES
BR112012015597A2 (pt) 2009-12-21 2017-01-31 Ambrx Inc peptídeos de somatotropina suínos modificados e seus usos
US9815876B2 (en) 2010-03-05 2017-11-14 Omeros Corporation Chimeric inhibitor molecules of complement activation
US20110229921A1 (en) 2010-03-18 2011-09-22 Abbott Laboratories METHODS OF ASSAYING URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (uNGAL) IN THE PROGNOSIS OF CADAVERIC KIDNEY TRANSPLANT FUNCTION IN A PATIENT, INCLUDING A PATIENT DIAGNOSED WITH DELAYED GRAFT FUNCTION (DGF), A METHOD OF ASSAYING uNGAL IN THE ASSESSMENT OF RISK OF DGF IN A PATIENT DIAGNOSED WITH EARLY GRAFT FUNCTION (EGF), AND RELATED KITS
WO2011163558A1 (en) 2010-06-25 2011-12-29 Abbott Laboratories Materials and methods for assay of anti-hepatitis c virus (hcv) antibodies
NZ607069A (en) 2010-08-17 2014-10-31 Ambrx Inc Modified relaxin polypeptides and their uses
AR083006A1 (es) 2010-09-23 2013-01-23 Lilly Co Eli Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas
US20120115244A1 (en) 2010-11-09 2012-05-10 Abbott Laboratories Materials and methods for immunoassay of pterins
CN107090441A (zh) 2010-12-09 2017-08-25 巴斯德研究所 用于获得高产量重组蛋白表达的基于mgmt的方法
DK2788478T3 (en) 2011-12-09 2017-10-09 Pasteur Institut Multiplex IMMUNSCREENINGSASSAY
US8993248B2 (en) 2011-12-31 2015-03-31 Abbott Laboratories Truncated human vitamin D binding protein and mutation and fusion thereof and related materials and methods of use
SG11201403988WA (en) 2012-02-09 2014-10-30 Var2 Pharmaceuticals Aps Targeting of chondroitin sulfate glycans
EP2906693A1 (en) 2012-10-15 2015-08-19 Novo Nordisk Health Care AG Coagulation factor vii polypeptides
JP2014128262A (ja) * 2012-11-27 2014-07-10 Kirin Brewery Co Ltd 接合能を持つ酵母細胞株のスクリーニング方法
BR112020022288A2 (pt) 2018-05-01 2021-02-23 Ambrx, Inc. método para otimizar a expressão de anticorpos
US20210278406A1 (en) 2018-07-13 2021-09-09 Varct Diagnostic Aps Isolation of circulating cells of fetal origin using recombinant malaria protein var2csa
US12049485B2 (en) 2018-09-11 2024-07-30 Ambrx, Inc. Interleukin-2 polypeptide conjugates and their uses
WO2020082057A1 (en) 2018-10-19 2020-04-23 Ambrx, Inc. Interleukin-10 polypeptide conjugates, dimers thereof, and their uses
AU2020223031B2 (en) 2019-02-12 2024-08-29 Ambrx, Inc. Compositions containing, methods and uses of antibody-TLR agonist conjugates
CN115243726B (zh) 2020-03-11 2025-07-15 北京泰德制药股份有限公司 白介素-2多肽偶联物及其使用方法
WO2021211331A1 (en) 2020-04-13 2021-10-21 Abbott Point Of Care Inc. METHODS, COMPLEXES AND KITS FOR DETECTING OR DETERMINING AN AMOUNT OF A ß-CORONAVIRUS ANTIBODY IN A SAMPLE
US20220043000A1 (en) 2020-08-04 2022-02-10 Abbott Laboratories Methods and kits for detecting sars-cov-2 protein in a sample
US20230302150A1 (en) 2020-08-20 2023-09-28 Ambrx, Inc. Antibody-tlr agonist conjugates, methods and uses thereof
EP4271998A1 (en) 2020-12-30 2023-11-08 Abbott Laboratories Methods for determining sars-cov-2 antigen and anti-sars-cov-2 antibody in a sample
JP2024512775A (ja) 2021-04-03 2024-03-19 アンブルックス,インコーポレイテッド 抗her2抗体薬物コンジュゲート及びその使用
CN115806889B (zh) * 2022-09-28 2024-06-11 山东大学 一种提高基因表达水平的酿酒酵母工程菌及其构建方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4546082A (en) * 1982-06-17 1985-10-08 Regents Of The Univ. Of California E. coli/Saccharomyces cerevisiae plasmid cloning vector containing the alpha-factor gene for secretion and processing of hybrid proteins
US4613572A (en) * 1983-08-15 1986-09-23 Kansas State University Research Foundation Yeast BAR1 gene plasmid
JPS61247384A (ja) * 1984-10-18 1986-11-04 チモ−ジエネテイツクス インコ−ポレ−テツド 酵母中でプラスミノ−ゲン活性化因子を発現する方法
DE3537176C2 (de) * 1984-10-18 1994-06-09 Zymogenetics Inc Gewebeplasminogenaktivator und Verfahren zu seiner Herstellung

Also Published As

Publication number Publication date
HU206897B (en) 1993-01-28
JPS63501614A (ja) 1988-06-23
DK320287A (da) 1987-06-23
SK279041B6 (sk) 1998-06-03
FI872801A7 (fi) 1987-06-24
IE862804L (en) 1987-04-25
AU7400391A (en) 1991-07-18
AU6543286A (en) 1987-05-19
JP2523562B2 (ja) 1996-08-14
IE63822B1 (en) 1995-06-14
EP0243465A1 (en) 1987-11-04
WO1987002670A1 (en) 1987-05-07
CZ776486A3 (en) 1996-09-11
CZ284251B6 (cs) 1998-10-14
CN1027179C (zh) 1994-12-28
CN86107554A (zh) 1987-08-26
DK320287D0 (da) 1987-06-23
AU676132B2 (en) 1997-03-06
CA1316133C (en) 1993-04-13
HUT43624A (en) 1987-11-30
SK776486A3 (en) 1998-06-03
UA41863C2 (uk) 2001-10-15

Similar Documents

Publication Publication Date Title
FI872801A7 (fi) Foerfarande foer anvaendning av bar1 foer avsoendring av fraemmande proteiner.
FI850004A0 (fi) Foerfarande foer identifiering av nukleinsyror.
FI850090A0 (fi) Foerfarande foer framstaellning av naturstensimitationer.
FI850605A0 (fi) Foerfarande foer framstaellning av formar.
FI862678L (fi) Skaeranordning foer plattor av plastmaterial.
FI850951A0 (fi) Foerfarande foer framstaellning av kisel.
FI873436L (fi) Anordning foer foervaermning av friskluft.
FI860957A0 (fi) Foerfarande foer foersnabbande av fixeringen av kromathaltiga traeskyddssalter.
FI850208L (fi) Foerfarande foer styrning av alkaliska cellulosakok.
FI850686L (fi) Foerfarande foer framstaellning av en flygskaerm.
FI850864L (fi) Foerfarande foer framstaellning av ribonukleinsyra.
FI850120A0 (fi) Automatiseringsmetod av glasboejningsung.
FI850353A0 (fi) Aendspont foer kantstoed av betong.
FI851098A0 (fi) Maetanordning foer maetning av en mediumstroems volymstroem.
FI850952L (fi) Foerpackning av jaest foer bakningsaendamaol.
FI850102A0 (fi) Stoedanordning foer uppoevningsanlaeggning av en oegon-hand-koordination.
FI850937A0 (fi) Foerfarande foer framstaellning av traeskivor.
FI850931A0 (fi) Foerfarande foer tillvaratagande av vattnets tillfrysningsvaerme.
FI850876L (fi) Foerfarande foer emballering av pappersrullar.
FI850059A0 (fi) Foerfarande foer framstaellning av en hylsa.
FI850031A0 (fi) Foerfarande foer anaerob rengoering av avfallsvatten.
FI850001A0 (fi) Anordning foer maetning av haerdningsgrad av betong.
FI850399L (fi) Uppvaermbart verktyg foer upphettning av roerfoerbindningsstycken.
FI850333A0 (fi) Anvaendning av torvaska.
FI850683L (fi) Anordning foer korsmaetning av fordon.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: ZYMOGENETICS, INC.